5-(3-buten-1-yl)-3-phenyl-oxazolidin-2-one | 1174337-24-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑烷类
• 英文名称: 5-(3-buten-1-yl)-3-phenyl-oxazolidin-2-one
• 英文别名: 5-but-3-en-1-yl-3-phenyl-1,3-oxazolidin-2-one；5-But-3-enyl-3-phenyl-1,3-oxazolidin-2-one
• CAS: 1174337-24-6
• 化学式: C₁₃H₁₅NO₂
• 分子量: 217.268
• InChiKey: OZAJGVFWNPFREQ-UHFFFAOYSA-N

物化性质

• 沸点：
  305.9±9.0 °C(Predicted)
• 密度：
  1.101±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.31
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1,2-环氧基-5-己烯 、 异氰酸苯酯 在 三乙基铵碘化物 作用下， 以 neat (no solvent) 为溶剂， 反应 1.0h， 以71%的产率得到5-(3-buten-1-yl)-3-phenyl-oxazolidin-2-one
  参考文献：
  名称：

  三乙胺碘化氢作为双功能催化剂，可无溶剂合成2-恶唑烷酮

  摘要：

  开发了在无溶剂条件下由环氧化物和异氰酸酯有效合成2-恶唑烷酮的方法，该方法以三乙胺碘化氢为简单有效的双功能有机催化剂。

  DOI：

  10.1002/ejoc.202000771

文献信息

• Transformation of Carbon Dioxide into Oxazolidinones and Cyclic Carbonates Catalyzed by Rare-Earth-Metal Phenolates
  作者：Bin Xu、Peng Wang、Min Lv、Dan Yuan、Yingming Yao

  DOI：10.1002/cctc.201600534

  日期：2016.8.8

  Rare‐earth‐metal complexes stabilized by amine‐bridged tri(phenolato) ligands were developed, and their activities in catalyzing transformations of CO2 were studied. A series of terminal epoxides and challenging disubstituted epoxides were converted into the respective cyclic carbonates in the presence of CO2 in yields of 58 to 96 %. In addition, these rare‐earth‐metal complexes also showed good activities

  开发了由胺桥联的三（酚）配体稳定的稀土金属配合物，并研究了它们在催化CO 2转化中的活性。在CO 2存在下，将一系列末端环氧化物和具有挑战性的二取代环氧化物转化为相应的环状碳酸酯，产率为58％至96％。此外，这些稀土金属配合物在催化苯胺，环氧化物和CO 2的三组分反应中也表现出良好的活性，可生成5-取代-3-芳基-2-恶唑烷，产率为48％至96％，作为构建恶唑烷酮的有用策略。
• Conversion of Carbon Dioxide into Oxazolidinones Mediated by Quaternary Ammonium Salts and DBU
  作者：Min Lv、Peng Wang、Dan Yuan、Yingming Yao

  DOI：10.1002/cctc.201700594

  日期：2017.12.20

  A straightforward method to construct oxazolidinones through a three‐component reaction involving CO2, epoxides, and amines promoted by a combination of Bu4NI and 1,8‐diazabicyclo[5.4.0]undec‐7‐ene was developed. A wide range of aromatic and aliphatic amines and monosubstituted epoxides were converted into 3,5‐disubstituted‐2‐oxazolidines in up to 95 % yield. This metal‐free and easily available catalytic

  开发了一种简单的方法，通过Bu 4 NI和1,8-二氮杂双环[5.4.0] undec-7-ene的组合促进的涉及CO 2，环氧化物和胺的三组分反应来构建恶唑烷酮。各种各样的芳香族和脂肪族胺以及单取代的环氧化物以高达95％的产率转化为3,5-二取代-2-恶唑烷。这种无金属且易于获得的催化体系可在大气压下适用于多种基材，包括传统上具有挑战性的基材，例如脂族环氧化物。初步的机理研究表明，涉及β-氨基醇的反应途径。
• A Multicomponent Approach to Oxazolidinone Synthesis Catalyzed by Rare‐Earth Metal Amides
  作者：Meixia Zhou、Xizhou Zheng、Yaorong Wang、Dan Yuan、Yingming Yao

  DOI：10.1002/cctc.201900221

  日期：2019.12.5

  Three‐component reaction of epoxides, amines, and dimethyl carbonate catalyzed by rare‐earth metal amides has been developed to synthesize oxazolidinones. 47 examples of 3,5‐disubstituted oxazolidinones were prepared in 13–97 % yields. This is a simple and most practical method which employs easily available substrates and catalysts, and is applicable to a wide range of aromatic and aliphatic amines

  已开发了稀土金属酰胺催化的环氧化物，胺和碳酸二甲酯的三组分反应，以合成恶唑烷酮。制备了47个3,5-二取代的恶唑烷酮实例，产率为13–97％。这是一种简单且最实用的方法，它使用易于获得的底物和催化剂，适用于各种芳族和脂族胺以及单取代的环氧化物。二取代的环氧化物的范围相当有限，这需要进一步研究。初步的机理研究揭示了通过β-氨基醇或酰胺中间体产生的两种可能的反应途径。
• [EN] 3,5-SUBSTITUTED-1,3-OXAZOLIDIN-2-ONE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1,3-OXAZOLIDIN-2-ONE 3,5-SUBSTITUÉE
  申请人：MERCK & CO INC

  公开号：WO2009094265A1

  公开（公告）日：2009-07-30

  The present invention is directed to 3,5-disubstituted-l,3-oxazolidin~2-one derivatives which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.

  本发明涉及3,5-二取代-1,3-噁唑烷-2-酮衍生物，其是代谢型谷氨酸受体的增效剂，包括mGluR2受体，适用于治疗或预防与谷氨酸功能障碍有关的神经系统和精神疾病以及代谢型谷氨酸受体参与的疾病。该发明还涉及包含这些化合物的制药组合物以及这些化合物和组合物在预防或治疗涉及代谢型谷氨酸受体的疾病中的用途。
• 3,5-SUBSTITUTED-1,3-OXAZOLIDIN-2-ONE DERIVATIVES
  申请人：Brnardic Edward

  公开号：US20100292241A1

  公开（公告）日：2010-11-18

  The present invention is directed to 3,5-disubstituted-1,3-oxazolidin-2-one derivatives which are potentiators of metabotropic glutamate receptors, including the mGluR2 receptor, and which are useful in the treatment or prevention of neuro-ological and psychiatric disorders associated with glutamate dysfunction and diseases in which metabotropic glutamate receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which metabotropic glutamate receptors are involved.

  本发明涉及3,5-二取代-1,3-噁唑烷-2-酮衍生物，其为代谢型谷氨酸受体的增强剂，包括mGluR2受体，可用于治疗或预防与谷氨酸功能失调相关的神经学和精神疾病以及代谢型谷氨酸受体参与的疾病。本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗代谢型谷氨酸受体参与的疾病中的使用。